Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Epilepsy characterized by intractable complex partial seizures (Disease Or Phenotype)

Id:e45202a8-d554-5b22-a1aa-662d054ac676

Results found

Linked to

	Label	Description
	phenytoin indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Phenobarbital indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	valproic acid indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	levetiracetam indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Salacetamide indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	vigabatrin indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lamotrigine indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	tiagabine indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	sulfamic acid (3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-tetrahydro-benzo[1,2-d,3,4-d']bis[1,3]dioxol-3a-ylmethyl ester indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fosphenytoin indication Epilepsy characterized by intractable complex partial seizures Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

phenytoin indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Phenobarbital indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

valproic acid indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

levetiracetam indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Salacetamide indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

vigabatrin indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

lamotrigine indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

tiagabine indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

sulfamic acid (3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-tetrahydro-benzo[1,2-d,3,4-d']bis[1,3]dioxol-3a-ylmethyl ester indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fosphenytoin indication Epilepsy characterized by intractable complex partial seizures

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.